| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2098.27 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1751.41 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1828.11 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 1875.03 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2032.79 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1902.52 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1495.31 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2147.18 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1671.52 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1672.62 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2427.03 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1727.33 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2241.63 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1928.24 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2045.58 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2497.85 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1888.4 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2151.7 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2245.94 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2155.42 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2029.12 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2361.12 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2293.04 | 98 |